EPIDEMIOLOGY PROFILE OF PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASE (PID) UNDER REGULAR THERAPY WITH OR WITHOUT INTRAVENOUS IMMUNOGLOBULIN (IVIG) REPLACEMENT IN BRAZIL

被引：0
|
作者：
Lawrence, T. C. [1 ]
Scancetti, F. [2 ]
Silva, A. M. R. [3 ]
Goudouris, E. [4 ]
Ouricuri, A. L. [4 ]
Costa-Carvalho, B. T. [1 ]
机构：
[1] Univ Fed Sao Paulo, Sao Paulo, Brazil
[2] Hosp Crianca Dist Fed, Brasilia, DF, Brazil
[3] Univ Fed Pernambuco, Recife, PE, Brazil
[4] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2012年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：399 / 399
页数：1
相关论文
共 50 条
  • [1] Adverse Events (ae) to Intravenous Immunoglobulin (ivig) in Patients with Primary Immunodeficiency (pid) During Regular Replacement Therapy
    Bichuete-Silva, D. C.
    Furlan, F. P.
    Nobre, F. A.
    Pereira, C. T. M.
    Goncalves, T. R. T.
    Gouveia-Pereira, M.
    Rota, R.
    Mazzucchelli, J. L.
    Costa-Carvalho, B. T.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 : S110 - S110
  • [2] Efficacy, Pharmacokinetics And Tolerability Of IQYMUNE®, A Novel 10% Intravenous Immunoglobulin (IVIg), In Patients With Primary Immunodeficiency(PID
    Krivan, Gergely
    Chernyshova, Ludmila
    Kostyuchenko, Larysa
    Lange, Andrzej
    Nyul, Zoltan
    Derfalvi, Beata
    Musial, Jacek
    Bellon, Anne
    Kappler, Martin
    Sadoun, Alain
    Puget, Sophie
    Bernatowska, Ewa
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 : 19 - 19
  • [3] Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients
    H. W. Schroeder
    C. J. Dougherty
    Infection, 2012, 40 : 601 - 611
  • [4] Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients
    Schroeder, H. W., Jr.
    Dougherty, C. J.
    INFECTION, 2012, 40 (06) : 601 - 611
  • [5] Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
    Skoda-Smith, Suzanne
    Torgerson, Troy R.
    Ochs, Hans D.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 1 - 10
  • [6] INTRAVENOUS IMMUNOGLOBULIN (IVIG) THERAPY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES AT SULTAN QABOOS UNIVERSITY HOSPITAL, OMAN
    Al-Siyabi, N. K.
    Al-Tamemi, S. H.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 349 - 349
  • [7] Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency
    Wasserman, Richard L.
    Church, Joseph A.
    Peter, Hans H.
    Sleasman, John W.
    Melamed, Isaac
    Stein, Mark R.
    Bichler, Johann
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 37 (3-4) : 272 - 278
  • [8] Two young stroke patients associated with regular intravenous immunoglobulin (IVIg) therapy
    Nakano, Yumiko
    Hayashi, Takeshi
    Deguchi, Kentaro
    Sato, Kota
    Hishikawa, Nozomi
    Yamashita, Toru
    Ohta, Yasuyuki
    Takao, Yoshiki
    Morio, Tomohiro
    Abe, Koji
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 361 : 9 - 12
  • [9] LONG-TERM FOLLOW-UP OF PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY TREATED WITH INTRAVENOUS IMMUNOGLOBULIN - REEVALUATION OF INTRAVENOUS IMMUNOGLOBULIN REPLACEMENT THERAPY - IVIG THERAPY IN CVID
    MUSHIAKE, K
    MOTOYOSHI, F
    KONDO, N
    SHIMIZU, H
    ORII, T
    BIOTHERAPY, 1994, 7 (02) : 101 - 107
  • [10] Trough Concentrations of Specific Antibodies in Primary Immunodeficiency Patients Receiving Intravenous Immunoglobulin Replacement Therapy
    Hassin, Ori
    Abu Freih, Yahya
    Hazan, Ran
    Lev, Atar
    Zrihen, Keren S.
    Somech, Raz
    Broides, Arnon
    Nahum, Amit
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 9
12345